ProCrea
Next Fertility ProCrea is a Swiss fertility clinic in Lugano offering IUI, IVF/ICSI, egg donation, MicroTESE, and genetic testing to infertile couples, same-sex female couples, and individuals seeking fertility preservation across Switzerland and northern Italy.
- Company typePrivate
- Founded1999
- HeadquartersLugano, Switzerland
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What ProCrea does
Next Fertility ProCrea is a Swiss fertility clinic headquartered in Lugano, legally incorporated as Procrea Centro Fertilità Svizzera Italiana Sa, operating since 1999 and owned by the Next Fertility Group (Next Clinics) network spanning Italy, Switzerland, and Spain. The clinic provides a comprehensive range of assisted reproduction services centered on three core procedures — intrauterine insemination (IUI, €1,200), IVF/ICSI (€5,600), and egg donation (€7,600-€9,500) — supported by MicroTESE for non-obstructive azoospermia (sperm retrieval rates ~60%), oocyte and semen cryopreservation, full preimplantation genetic testing (PGT-A, PGT-SR, PGT-M, €700-€4,900), genetic matching (CGT), and non-invasive prenatal testing under the PrenatalNext sub-brand. The clinical team of 40+ professionals, including Scientific Director Dr. Giovanni M. Colpi (one of the world's leading MicroTESE specialists with 1,300+ procedures), operates from a 1,800 square meter facility housing embryology and andrology laboratories, two operating rooms, and recovery areas.
The business model is direct-to-consumer with a sales-led acquisition motion: patients book a free initial consultation (online or in-clinic), after which they pay per treatment cycle or per genetic analysis. Pricing is denominated in euros and publicly disclosed, with cryopreservation services generating recurring annual fees (€300/year from year 4 onward) on top of one-time treatment revenue. Geographic reach is regional with cross-border extension: primary catchment is Italian-speaking Switzerland (Ticino) and northern Italy (Lombardy), with a dedicated Italian phone line, and egg donation services coordinated with Next Fertility Spain and Italian partner clinics. Customer segments span infertile heterosexual couples, same-sex female couples (since 2022), women seeking social freezing, men with male-factor infertility (including azoospermia requiring MicroTESE), and oncology fertility preservation cases.
Go-to-market is multi-channel: a multilingual website (Italian, English, French, German), active social media presence on Facebook, Instagram, YouTube, and LinkedIn, patient testimonials, and educational content, complemented by a private patient portal (webportal.procrea.ch). The clinic is positioned as a premium, multidisciplinary fertility center offering complementary services such as psychotherapy, acupuncture, 3D-4D ultrasound, and menopause care under a "Centro della Salute" (Health Center) umbrella, reinforcing a patient-experience-led value proposition in a market where Swiss regulatory restrictions and clinical outcomes drive patient selection.
ProCrea firmographics
Firmographics- Name
- ProCrea
- Legal name
- Procrea Centro Fertilità Svizzera Italiana Sa
- Website
- https://nextfertilityprocrea.ch
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Next Fertility ProCrea is a Swiss fertility clinic in Lugano offering IUI, IVF/ICSI, egg donation, MicroTESE, and genetic testing to infertile couples, same-sex female couples, and individuals seeking fertility preservation across Switzerland and northern Italy.
- Ownership category
- akta.pro rank
ProCrea industry classification
Industry- Product category
- Fertility Clinic Services
- NAICS
- Family Planning Centers (62141)
- akta.pro primary industry
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
- akta.pro secondary industries
- Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)
Keywords
Where ProCrea is headquartered
LocationHeadquarters
- HQ city
- Lugano
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
ProCrea business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Assisted Reproduction Treatments: Revenue from fertility treatments including IUI (€1,200), IVF/ICSI (€5,600), IVF/ICSI natural cycle (€3,000), IVF/ICSI DUAL STIM (€9,400), egg donation with transfer to Italy (€7,600-€9,500 depending on blastocyst guarantee), oocyte cryopreservation, and thawing/embryo transfer (€2,000). First consultation is free.
- Genetic Testing Services: PGT-A (€850 first blastocyst, €700 subsequent), PGT-SR (€1,100 first, €950 subsequent), PGT-M (€1,750 setup + €3,150 analysis), genetic matching/CGT, and NIPT prenatal testing.
- Cryopreservation Services: Oocyte and sperm cryopreservation with annual renewal fees (€300/year for oocyte cryopreservation from fourth year onward).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | One time | Free first consultation |
| One time/ perpetual license | One time | IUI (Intrauterine Insemination) |
| One time/ perpetual license | One time | IVF/ICSI on natural cycle |
| One time/ perpetual license | One time | IVF/ICSI |
| One time/ perpetual license | One time | IVF/ICSI DUAL STIM |
| Unit Pricing | One time | PGT-A (Preimplantation Genetic Testing for Aneuploidy) |
| Unit Pricing | One time | PGT-SR (Structural Rearrangements) |
| Unit Pricing | One time | PGT-M (Monogenic Diseases) |
| One time/ perpetual license | One time | Thawing and embryo transfer |
| One time/ perpetual license | Multi-year contract | Oocyte cryopreservation |
| One time/ perpetual license | Multi-year contract | Dual Stim oocyte cryopreservation |
| One time/ perpetual license | One time | Egg donation with transfer to Italy (1 blastocyst guaranteed) |
| One time/ perpetual license | One time | Egg donation with transfer to Italy (2 blastocysts guaranteed) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
ProCrea product offering
Product offeringCore offering
Next Fertility ProCrea is a Swiss fertility clinic providing assisted reproduction treatments, including intrauterine insemination (IUI), in vitro fertilization (IVF/ICSI), egg donation programs, micro-surgical sperm retrieval (MicroTESE), and oocyte/sperm cryopreservation (social freezing). The clinic complements these procedures with preimplantation genetic testing (PGT-A, PGT-SR, PGT-M), carrier genetic matching, NIPT prenatal screening, 3D-4D ultrasound diagnostics, psychotherapeutic support, and acupuncture, delivered from a 1,800 sqm facility in Lugano with on-site embryology and andrology laboratories.
Product overview
Next Fertility ProCrea is a Swiss fertility clinic offering a comprehensive range of assisted reproduction treatments centered around three core procedures: Intrauterine Insemination (IUI), In Vitro Fertilization (IVF/ICSI), and Egg Donation. The clinic provides complementary services including fertility preservation (oocyte and semen cryopreservation), advanced genetic testing (PGT-A, PGT-SR, PGT-M), genetic matching, and NIPT prenatal testing. Support services include genetic counseling, psychotherapeutic support, acupuncture, and 3D-4D ultrasound diagnostics. The facility features embryology and andrology laboratories, two operating rooms, and a private patient portal (webportal.procrea.ch) for managing patient information. Located in Lugano since 1999, the clinic is part of the Next Fertility Group network.
Differentiator
Problem solved
Functional benefit
Brands
- PrenatalNext: Non-invasive prenatal testing (NIPT) service for chromosomal abnormality screening during pregnancy.
- PrenatalNext (NIPT)
Products and services
- Intrauterine Insemination (IUI)
Quantifiable outcome
- Approximately 90% oocyte survival rate after vitrification and thawing
- +3 more outcomes
Companies that use ProCrea
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
ProCrea technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
ProCrea partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Next Fertility Group / Next ClinicscoreNext Fertility ProCrea is part of the Next Clinics / Next Fertility international group of fertility centers. The group provides shared standards, protocols, and best practices across its network of clinics, enabling access to international expertise and coordinated research.
- Next Fertility SpaincoreEgg donation services are provided through collaboration with Next Fertility Spain, where donors are recruited and blastocysts are created. This partnership enables guaranteed blastocyst outcomes (1 or 2) for egg donation treatments, with embryo transfer performed at Italian collaboration centers.
- Centro Medico Le Betulle (Appiano Gentile, Como - Italy)coreItalian collaboration center where embryo transfers are performed for egg donation treatments. Part of the cross-border treatment program where egg donation occurs in Spain and embryo transfer is performed in Italy.
- Rete Donna Svizzera (Swiss Women's Network)minorNext Fertility ProCrea supports Rete Donna Svizzera, a women's health network, demonstrating commitment to women's health awareness and community engagement.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
ProCrea competitors and assessment
Company assessmentBroad incumbents
- CCRM (Colorado Center for Reproductive Medicine):
- CARE Fertility: UK-headquartered fertility clinic group offering IVF, ICSI, egg donation, and PGT across multiple UK sites. Comparable in service breadth (full reproductive medicine), cross-border patient ambitions, and clinical technology stack.
- IVI RMA Global: One of the world's largest fertility clinic networks (IVI + RMA merger), with major presence across Spain and Europe. Directly comparable to ProCrea as a multi-country IVF/IUI/egg donation provider with cross-border patient programs — a much larger scale competitor in the same addressable market.
Direct peers
- Next Fertility Italia (Next Fertility Milano): Sister clinic within the Next Fertility Group network, located in Milan. Operates the same IVF/ICSI, egg donation, and PGT service portfolio targeting Italian patients. Most directly comparable peer given shared brand, protocols, and patient acquisition overlap.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
ProCrea social profiles
Digital presenceProCrea financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProCrea leadership team
Management profileNumber of profiles
Profiles8 records
ProCrea funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProCrea M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProCrea
What does ProCrea do?
Next Fertility ProCrea is a Swiss fertility clinic providing assisted reproduction treatments, including intrauterine insemination (IUI), in vitro fertilization (IVF/ICSI), egg donation programs, micro-surgical sperm retrieval (MicroTESE), and oocyte/sperm cryopreservation (social freezing). The clinic complements these procedures with preimplantation genetic testing (PGT-A, PGT-SR, PGT-M), carrier genetic matching, NIPT prenatal screening, 3D-4D ultrasound diagnostics, psychotherapeutic support, and acupuncture, delivered from a 1,800 sqm facility in Lugano with on-site embryology and andrology laboratories.
Is ProCrea a public or private company?
ProCrea is a private company. It is classified as corporate owned and is currently operating.
When was ProCrea founded?
ProCrea was founded in 1999. It employs 501 to 1,000 people.
Where is ProCrea based?
ProCrea is headquartered in Lugano, Switzerland, in the Europe region.
How does ProCrea make money?
Three revenue lines are on record. Assisted Reproduction Treatments are the primary driver. The others are genetic Testing Services and cryopreservation Services.
Who are ProCrea's main competitors?
Broad incumbents on record are CCRM (Colorado Center for Reproductive Medicine), CARE Fertility and IVI RMA Global. Next Fertility Italia (Next Fertility Milano) is listed as a direct peer.
Does ProCrea have an API?
No public API is recorded for ProCrea.
What industry is ProCrea in?
ProCrea's product category is Fertility Clinic Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 62141.